Investor relations

Vironova Medical in the inventor of the novel thionation reagent JBR, a patented chemical process technology used in pharmaceuticals and other areas. The JBR reagent and process are available for out-licensing. We are always looking for partners to collaborate with across different industries where the thionation technology can be applied.

Feel free to contact us below if you have any questions. You can always send an email directly to our investor relations team on:

ir@vironovamedical.com.

The Vironova Medical Group consists of four companies

Vironova Medical AB is the mother company.
Vironova Thionation AB, the vehicle for the Thionation project, is a partly owned subsidiary to Vironova Medical as well as Vironova Influenza AB and Vironova Herpes AB.